Tamoxifen’s Power Comes From Endoxifen, Which They Say Could Potentially Be Turned Into A Breast Cancer Drug
Mayo Clinic researchers have discovered that a chemical known as endoxifen appears to be the primary metabolite responsible for the effectiveness of tamoxifen in treating breast cancer, and that it works against cancer in an entirely unexpected way.
More: continued here
Filed under: Conferences on December 19th, 2008